Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0090
+0.0010 (12.50%)
Nov 11, 2026, 10:02 AM AEDT
Algorae Pharmaceuticals Market Cap
Algorae Pharmaceuticals has a market cap or net worth of 18.25 million as of November 10, 2026. It is the 40,018th most valuable company in the world and the 1,090th biggest in Australia. Its market cap has increased by 20.16% in one year.
Market Cap
18.25M
Enterprise Value
14.31M
Revenue
n/a
Global Rank
Country Rank
#1,090 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 1, 2004, Algorae Pharmaceuticals's market cap has increased from 12.17M to 18.25M, an increase of 49.97%. That is a compound annual growth rate of 1.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 16.22M | -31.39% |
| Dec 31, 2025 | 23.64M | 133.52% |
| Dec 30, 2024 | 10.12M | -39.06% |
| Dec 29, 2023 | 16.61M | 7.70% |
| Dec 30, 2022 | 15.42M | 185.23% |
| Dec 30, 2021 | 5.41M | -32.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Botanix Pharmaceuticals | 22.10M |
| Miro Sciences | 17.54M |
| Imugene | 17.14M |
| Argenica Therapeutics | 16.70M |
| Proteomics International Laboratories | 16.04M |
| ReNerve | 14.47M |
| EZZ Life Science Holdings | 14.12M |
| Ceryvyn Therapeutics | 13.68M |